Research Site

Haarlem 2035 RC

1 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Anemia, Cardiovascular Disease, Chronic Lymphocytic Leukemia, Congestive Heart Failure, Diabetes Mellitus, Non-Insulin-Dependent, Fracture Healing, Heart Failure, High Risk for Cardiovascular Event, Prostate Cancer Metastatic, Stable Coronary Artery Disease (CAD), Myocardial Infarction, Ventricular Dysfunction

Studies at this site

• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin — Recruiting now
• Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL) — Running, not enrolling
• RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial — Completed
• Study To Assess FRacTure Healing With SclerosTin Antibody - Hip — Completed
• Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events — Completed
• Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients — Stopped early
• EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer — Completed
• A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome — Completed